The genomic analysis of The Cancer Genome Atlas (TCGA) and the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) databases confirmed that the amplification of FGFR1 is the most common type of FGFR alteration, occurring in nearly 14% of patients with breast cancer [40]. The gene discussed is FGFR1; the disease is breast carcinoma.